David O Cosgrove

Summary

Country: UK

Publications

  1. ncbi Renal transplants: what ultrasound can and cannot do
    David O Cosgrove
    Department of Imaging Sciences, Imperial College of Medicine, Hammersmith Hospital, London, United Kingdom
    Ultrasound Q 24:77-87; quiz 141-2. 2008
  2. ncbi Hepatic vein transit time of SonoVue: a comparative study with Levovist
    Adrian K P Lim
    Imaging Sciences Department, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Rd, London W12 0HS, England
    Radiology 240:130-5. 2006
  3. ncbi Can Doppler sonography grade the severity of hepatitis C-related liver disease?
    Adrian K P Lim
    Imaging Sciences Department, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, Du Cane Rd, London W12 0HS, UK
    AJR Am J Roentgenol 184:1848-53. 2005
  4. ncbi A novel technique to measure splanchnic transit time using microbubble ultrasound
    Michele Marshall
    Intestinal Imaging Centre, St. Mark's Hospital, London, UK
    Invest Radiol 40:80-4. 2005
  5. ncbi Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study
    Thomas H Bryant
    Imaging Sciences Department, Hammersmith Hospital, Imperial College, 150 Du Cane Rd, London W12 0HS, England
    Radiology 232:799-809. 2004
  6. ncbi Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers
    Adrian K P Lim
    Imaging Sciences Department, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, DuCane Rd, London W12 0HS, England, UK
    Radiology 231:785-8. 2004
  7. ncbi Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study
    Thomas Albrecht
    Dept of Radiology and Nuclear Medicine, Universitatsklinikum Benjamin Franklin, Freie Universitat Berlin, Hindenburgdamm 30, Germany
    Radiology 227:361-70. 2003
  8. ncbi Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles
    Christopher J Harvey
    Department of Imaging Sciences, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
    Eur Radiol 12:S70-3. 2002
  9. ncbi Heterogeneous delayed enhancement of the liver after ultrasound contrast agent injection--a normal variant
    Masahiro Okada
    Department of Radiology and Nuclear Medicine, , , Berlin, Germany
    Ultrasound Med Biol 28:1089-92. 2002
  10. ncbi The first phase I study of a novel ultrasound contrast agent (BR14): assessment of safety and efficacy in liver and kidneys
    Raffaella Basilico
    Department of Radiology, University of Chieti, Italy
    Acad Radiol 9:S380-1. 2002

Collaborators

Detail Information

Publications14

  1. ncbi Renal transplants: what ultrasound can and cannot do
    David O Cosgrove
    Department of Imaging Sciences, Imperial College of Medicine, Hammersmith Hospital, London, United Kingdom
    Ultrasound Q 24:77-87; quiz 141-2. 2008
    ..There is hope that some of the newer ultrasound methods, especially the functional data from microbubble contrast agent dynamics, might supply useful information for their detection and differentiation...
  2. ncbi Hepatic vein transit time of SonoVue: a comparative study with Levovist
    Adrian K P Lim
    Imaging Sciences Department, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Rd, London W12 0HS, England
    Radiology 240:130-5. 2006
    ..To prospectively compare transit times of Levovist and SonoVue in healthy volunteers and patients with biopsy-proved hepatitis C-related liver disease...
  3. ncbi Can Doppler sonography grade the severity of hepatitis C-related liver disease?
    Adrian K P Lim
    Imaging Sciences Department, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, Du Cane Rd, London W12 0HS, UK
    AJR Am J Roentgenol 184:1848-53. 2005
    ....
  4. ncbi A novel technique to measure splanchnic transit time using microbubble ultrasound
    Michele Marshall
    Intestinal Imaging Centre, St. Mark's Hospital, London, UK
    Invest Radiol 40:80-4. 2005
    ..CONCLUSION: Splanchnic transit time may be measured by microbubble injection but is subject to considerable measurement error. Newer microbubbles and imaging methods may allow more reproducible measurements...
  5. ncbi Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study
    Thomas H Bryant
    Imaging Sciences Department, Hammersmith Hospital, Imperial College, 150 Du Cane Rd, London W12 0HS, England
    Radiology 232:799-809. 2004
    ....
  6. ncbi Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers
    Adrian K P Lim
    Imaging Sciences Department, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, DuCane Rd, London W12 0HS, England, UK
    Radiology 231:785-8. 2004
    ..To evaluate the pharmacokinetics of the microbubble contrast agent BR1...
  7. ncbi Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study
    Thomas Albrecht
    Dept of Radiology and Nuclear Medicine, Universitatsklinikum Benjamin Franklin, Freie Universitat Berlin, Hindenburgdamm 30, Germany
    Radiology 227:361-70. 2003
    ....
  8. ncbi Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles
    Christopher J Harvey
    Department of Imaging Sciences, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
    Eur Radiol 12:S70-3. 2002
    ..The use of liver-specific microbubble US contrast agents is an exciting development in the detection of HCC in chronic liver disease and may help to rectify some of the shortcomings of US...
  9. ncbi Heterogeneous delayed enhancement of the liver after ultrasound contrast agent injection--a normal variant
    Masahiro Okada
    Department of Radiology and Nuclear Medicine, , , Berlin, Germany
    Ultrasound Med Biol 28:1089-92. 2002
    ..It was observed with two different contrast agents. The cause of the described effect is unknown; it may be related to the formation of large bubbles and vascular entrapment of these bubbles in the liver...
  10. ncbi The first phase I study of a novel ultrasound contrast agent (BR14): assessment of safety and efficacy in liver and kidneys
    Raffaella Basilico
    Department of Radiology, University of Chieti, Italy
    Acad Radiol 9:S380-1. 2002
  11. ncbi Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma
    Robert J Eckersley
    Ultrasound Group, Imaging Sciences Department, Clinical Sciences Centre, Imperial College Medical School, Hammersmith Campus, London, United Kingdom
    Prostate 51:256-67. 2002
    ..We quantified changes in prostate carcinoma vascularity treated with anti-androgens using color Doppler and power transrectal ultrasound in combination with microbubble contrast agent Levovist...
  12. ncbi Initial observations on the effect of irradiation on the liver-specific uptake of Levovist
    Emilio Quaia
    Department of Radiology, Imperial College School of Medicine (Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK
    Eur J Radiol 41:192-9. 2002
    ..The two likely mechanisms would be damage to the Kupffer cells and or the vascular endothelium, although the relative contribution of these is unclear...
  13. ncbi Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?
    Raffaella Basilico
    Department of Radiology, University of Chieti, Policlinico SS Annunziata, Via dei Vestini, 66013 Chieti, Italy
    Eur J Radiol 41:184-91. 2002
    ..A variety of linear and nonlinear scanning modes are now available, but it is unclear which is optimal. A controlled comparison was performed during the infusion of such an agent (SonoVue: Bracco, Milan, Italy)...
  14. ncbi Enhancement characteristics of the microbubble agent Levovist: reproducibility and interaction with aspirin
    Rolf A Heckemann
    Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
    Eur J Radiol 41:179-83. 2002
    ..Aspirin does not have a significant effect on enhancement indices except carotid spectral Doppler decay. We conclude that aspirin is unlikely to potentiate microbubble enhancement, as seen in animal studies...